Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y. Agid

Showing results (61-70 of 611) with videos related to

Pageof 62
Sort By:
Archives of Neurology|May 1, 1978
Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopaF Lhermitte, Y Agid, J L Signoret
Neurology|September 1, 1986
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's diseaseB Pillon, B Dubois, F Lhermitte, et al.
Brain Research|February 6, 1976
Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine systemF Javoy, C Sotelo, A Herbet, et al.
Revue Neurologique|April 12, 2003
[Parkinson's disease: cell death mechanisms]P.-P. Michel, E.-C. Hirsch, Y. Agid
Brain Research|November 26, 1984
Adrenergic receptors in Parkinson's diseaseR Cash, M Ruberg, R Raisman, et al.
European Journal of Pharmacology|February 5, 1985
Adrenergic receptors in frontal cortex in human brainR Cash, R Raisman, M Ruberg, et al.
Journal of Neurochemistry|April 1, 1988
[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brainD Scherman, R Raisman, A Ploska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Worsening of levodopa-induced dyskinesias by motor and mental tasksF Durif, M Vidailhet, B Debilly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Tremor and idiopathic dystoniaC P Jedynak, A M Bonnet, Y Agid
Advances in Neurology|January 1, 1990
The nigrostriatal system in Parkinson's diseaseA M Graybiel, E C Hirsch, Y Agid
Pageof 62

Showing results (61-70 of 611) with videos related to

Sort By:
Pageof 62
Archives of Neurology|May 1, 1978
Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopaF Lhermitte, Y Agid, J L Signoret
Neurology|September 1, 1986
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's diseaseB Pillon, B Dubois, F Lhermitte, et al.
Brain Research|February 6, 1976
Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine systemF Javoy, C Sotelo, A Herbet, et al.
Revue Neurologique|April 12, 2003
[Parkinson's disease: cell death mechanisms]P.-P. Michel, E.-C. Hirsch, Y. Agid
Brain Research|November 26, 1984
Adrenergic receptors in Parkinson's diseaseR Cash, M Ruberg, R Raisman, et al.
European Journal of Pharmacology|February 5, 1985
Adrenergic receptors in frontal cortex in human brainR Cash, R Raisman, M Ruberg, et al.
Journal of Neurochemistry|April 1, 1988
[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brainD Scherman, R Raisman, A Ploska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Worsening of levodopa-induced dyskinesias by motor and mental tasksF Durif, M Vidailhet, B Debilly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Tremor and idiopathic dystoniaC P Jedynak, A M Bonnet, Y Agid
Advances in Neurology|January 1, 1990
The nigrostriatal system in Parkinson's diseaseA M Graybiel, E C Hirsch, Y Agid
Pageof 62